Fritextsökning
Innehållstyper
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
De ska basa över Scilifelab
I dag tog regeringen beslut om hur forskningscentrumet Scilifelab ska styras.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Enzymatisk upprening av PCR-reaktioner
HT Exosap-IT Fast är ett reagens som i ett pipetteringssteg tillåter upprening av PCR-reaktioner.
-
Precisionsmedicinen är här och i framtiden
Precisionsmedicinen har potentialen att omdana vår sjukvård och förvandla dödliga sjukdomar till kroniska. Men var står Sverige i utvecklingen? Life Science Swe...
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Dubbdäck tar fler liv än de räddar
Dubbarna river upp asfalt, vilket skördar fler liv än dubbarna räddar, enligt en ny studie inom ramen för programmet Mistra Environmental Nanosafety.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Nu ska Scilifelab granskas
Fem år efter starten ska forskningsinstitutet granskas.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Livsgärning nominerad till uppfinnarpris
- Det är överväldigande, att rädda någons liv, säger docent Tore Curstedt som nominerats till det europeiska uppfinnarpriset för sin livsgärning med att rädda n...
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Historiska beslut om genpatent
Lagstiftningen kring patentering av gener är under förändring. Nyligen kom två domar, en i Europa och en i USA, som kommer att påverka framtida bedömningar av patent på liv.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.